Brain implant device tracked for 5 years in epilepsy patients
NCT ID NCT02403843
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 345 people with epilepsy who already had a brain implant called the RNS System. The goal was to see how safe and effective the device is over 5 years in everyday medical practice. Researchers measured side effects, seizure reduction, and how well doctors could use the system.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Austin Epilepsy Care Center
Austin, Texas, 78758, United States
-
Dartmouth-Hitchcock Medical Cente
Lebanon, New Hampshire, 03756, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Intermountain Healthcare Research
Salt Lake City, Utah, 84157, United States
-
Le Bonheur Children's Hospital
Memphis, Tennessee, 38105, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
NYU Langone Medical Center
New York, New York, 10016, United States
-
Norton Neuroscience Institute
Louisville, Kentucky, 40241, United States
-
Pennsylvania State University / Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Seton Family of Hospital
Austin, Texas, 78701, United States
-
Spectrum Health
Grand Rapids, Michigan, 49503, United States
-
Stanford University
Palo Alto, California, 94304, United States
-
Swedish Health Services
Seattle, Washington, 98122, United States
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44193, United States
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Alabama, Birmingham
Birmingham, Alabama, 35294, United States
-
University of California, Irvine
Irvine, California, 92868, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
-
University of Kentucky
Lexington, Kentucky, 40506, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of South Florida
Tampa, Florida, United States
-
University of Southern California
Los Angeles, California, 90032, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-9036, United States
-
University of Utah
Salt Lake City, Utah, 84132-5901, United States
-
University of Washington Harborview Medical Center
Seattle, Washington, 98104, United States
-
University of Wisconsin-Madison
Madison, Wisconsin, 53705, United States
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
-
Yale University
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can community hospitals in zambia master severe disease care?
- Can mindfulness rewire the mind to lift depression in epilepsy?
- A break from seizure pills: could less medication mean better living?
- Can invisible electric fields quiet the Brain's seizure signals?
- Can a new drug tame severe childhood epilepsy?